Ibogaine Patents @ the USPO

Ibogaine Patents @ the United States Patent Office (USPO) Use of ibogaine in reducing excitotoxic brain damage Use of ibogaine in reducing excitotoxic brain damage This invention discloses that ibogaine, a plant derivative, can be used as a safe NMDA antagonist at relatively high dosages (including dosages high enough to …

Continue reading

Ibogaine in the Treatment of Chemical Dependence Disorders

Ibogaine in the Treatment of Chemical Dependence Disorders: Clinical Perspectives Copyright © 1994, Howard S. Lotsof All Rights Reserved Reproduced by permission of: The Ibogaine Dossier (Original Publication: MAPS – Volume 5, Number 3, Winter 1994-95) Dedicated to the work of J. Bastiaans and N. Adriaans In memory of N. …

Continue reading

Ibogaine: A Novel Anti-Addictive Compound…

Ibogaine: A Novel Anti-Addictive Compound A Comprehensive Literature Review By: Jonathan Freedlander Advisor: Carlo DiClemente, Ph.D. University of Maryland, Baltimore County Introduction and History Ibogaine is a naturally occurring indole alkaloid, found in a variety of African shrubs of the Tabernanthe genus (Obach, Pablo, and Mash, 1998). The root of …

Continue reading

Extraction studies of Tabernanthe iboga…

Original Reference: Nat Prod Lett 2002 Feb;16(1):71-6 Jenks CW. Extraction studies of Tabernanthe iboga and Voacanga africana Abstract: The root bark of Tabernanthe iboga contains ibogaine as its predominant alkaloid and has been an important source of it. Ibogaine is used experimentally to interrupt drug addiction and allow therapeutic intervention, …

Continue reading

Deborah Mash’s Brain

Copyright © 1995, Paul De Rienzo, Dana Beal and Members of the Project All Rights Reserved CHAPTER 18: Deborah Mash’s Brain In March, 1994, in strictest secrecy, Howard Lotsof re-instituted treatments of addict volunteers in an ultramodern hospital in Panama City, with pre-treatment work-ups at the University of Miami. But …

Continue reading